Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2022
Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and GlioblastomaJaehoon Shin, Matthew F L Parker, Iowis Zhu, et al.
Radiology. Imaging Cancer|March 29, 2024
<sup>18</sup>F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant ChemotherapyDevan Diwanji, Natsuko Onishi, Deep K Hathi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 2, 2024
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with <sup>18</sup>F-FDGBrad Kline, Surekha Yadav, Youngho Seo, et al.
ACS Applied Materials & Interfaces|November 9, 2021
Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane AntigenNiranjan Meher, Kyounghee Seo, Sinan Wang, et al.
ACS Sensors|October 25, 2023
Clinically Translatable Hyperpolarized <sup>13</sup>C Bicarbonate pH Imaging Method for Use in Prostate CancerChanghua Mu, Xiaoxi Liu, Yaewon Kim, et al.
Theranostics|February 23, 2024
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5Kondapa Naidu Bobba, Anil P Bidkar, Anju Wadhwa, et al.
Chemical Communications (Cambridge, England)|August 11, 2015
Application of Good's buffers to pH imaging using hyperpolarized (13)C MRIRobert R Flavell, Cornelius von Morze, Joseph E Blecha, et al.
Molecular Pharmaceutics|August 6, 2019
Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture TherapySinan Wang, Charles Blaha, Raquel Santos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate CancerRahul R Aggarwal, Jacqueline Vuky, David VanderWeele, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2022
Imaging joint infections using D-methyl-<sup>11</sup>C-methionine PET/MRI: initial experience in humansIlona Polvoy, Youngho Seo, Matthew Parker, et al.
Pageof 12